Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter Gale

Showing results (211-220 of 373) with videos related to

Pageof 38
Sort By:
Annals of Hematology|April 29, 2025
Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemiaAnna Turkina, Olga Vinogradova, Elza Lomaia, et al.
Chinese Journal of Cancer|May 21, 2016
Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantationYa-Zhen Qin, Yu Wang, Hong-Hu Zhu, et al.
Leukemia Research|February 22, 2018
Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasmsTariq I Mughal, Jason Gotlib, Ruben Mesa, et al.
Blood|May 4, 2007
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemiaHubert Schrezenmeier, Jakob R Passweg, Judith C W Marsh, et al.
Leukemia Research|December 29, 2015
BCL11A expression in acute myeloid leukemiaHuiquan Tao, Xiao Ma, Guangsong Su, et al.
Journal of Cancer|May 23, 2017
Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell TransplantationYee Chung Cheng, Yushu Shi, Mei-Jie Zhang, et al.
Leukemia|June 29, 2020
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infectionYing Wang, Yang Liu, Xu Tan, et al.
Blood|October 22, 2005
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantationHanna J Khoury, Fausto R Loberiza, Olle Ringdén, et al.
Bone Marrow Transplantation|May 14, 2021
The paradox of haematopoietic cell transplant in Latin AmericaGregorio Jaimovich, Robert Peter Gale, Ignacio Hanesman, et al.
Transplantation and Cellular Therapy|November 14, 2021
Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research StudyJun Zou, Tao Wang, Meilun He, et al.
Pageof 38

Showing results (211-220 of 373) with videos related to

Sort By:
Pageof 38
Annals of Hematology|April 29, 2025
Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemiaAnna Turkina, Olga Vinogradova, Elza Lomaia, et al.
Chinese Journal of Cancer|May 21, 2016
Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantationYa-Zhen Qin, Yu Wang, Hong-Hu Zhu, et al.
Leukemia Research|February 22, 2018
Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasmsTariq I Mughal, Jason Gotlib, Ruben Mesa, et al.
Blood|May 4, 2007
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemiaHubert Schrezenmeier, Jakob R Passweg, Judith C W Marsh, et al.
Leukemia Research|December 29, 2015
BCL11A expression in acute myeloid leukemiaHuiquan Tao, Xiao Ma, Guangsong Su, et al.
Journal of Cancer|May 23, 2017
Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell TransplantationYee Chung Cheng, Yushu Shi, Mei-Jie Zhang, et al.
Leukemia|June 29, 2020
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infectionYing Wang, Yang Liu, Xu Tan, et al.
Blood|October 22, 2005
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantationHanna J Khoury, Fausto R Loberiza, Olle Ringdén, et al.
Bone Marrow Transplantation|May 14, 2021
The paradox of haematopoietic cell transplant in Latin AmericaGregorio Jaimovich, Robert Peter Gale, Ignacio Hanesman, et al.
Transplantation and Cellular Therapy|November 14, 2021
Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research StudyJun Zou, Tao Wang, Meilun He, et al.
Pageof 38